Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 261
Japanese study takes SNM Image of the Year
By
Wayne Forrest
The annual SNM Image of the Year for 2010 comes from researchers at Hokko Memorial Hospital in Sapporo, who fused images of MDCT and technetium-99m sestamibi SPECT to provide information regarding detailed anatomical localization, angiography, and metabolism of an enlarged parathyroid gland.
June 13, 2010
AECL requests NRU restart hearing
By
AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) on June 11 requested a formal hearing before the Canadian Nuclear Safety Commission to restart medical isotope production at its National Research Universal (NRU) nuclear reactor in Chalk River, Ontario.
June 13, 2010
Lantheus' F-18 PET agent shows good dosing ratio
By
AuntMinnie.com staff writers
Preliminary phase II data suggest the uptake properties of Lantheus Medical Imaging's investigational PET agent flurpiridaz F-18 injection allow for a relatively low dosing ratio and a delay of 30 to 60 minutes between rest and stress injections, depending on the mode of stress used.
June 10, 2010
Covidien sees good Tc-99m supply in June
By
AuntMinnie.com staff writers
With the BR2 nuclear reactor in Belgium back online, healthcare technology firm Covidien is predicting more reliable supplies of technetium-99m (Tc-99m) for the rest of June.
June 10, 2010
AECL's NRU repairs at 98%
By
AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) has reported that repairs to its National Research Universal (NRU) nuclear reactor in Chalk River, Ontario, are 98% complete.
June 10, 2010
F-18 NaF PET/CT can help with atherosclerotic plaque detection
By
Wayne Forrest
German researchers have found that F-18 sodium fluoride (F-18 NaF) PET/CT may provide "relevant information about the morphologic and functional properties of calcified plaque," according to a study published in the June issue of the
Journal of Nuclear Medicine
.
June 10, 2010
SNM 2010 Roundup: News from Salt Lake City
By
Wayne Forrest
June 10, 2010
GE to collaborate with Neuroimage
By
AuntMinnie.com staff writers
GE Healthcare has inked a collaboration with its Medical Diagnostics Imanet business and Neuroimage to develop neuroimaging and biomarker technologies to support clinical trials.
June 9, 2010
GE touts PET agent study at SNM
By
AuntMinnie.com staff writers
GE Healthcare presented results from an interim phase II study of its developmental fluciclatide radiopharmaceutical at this week's SNM annual meeting in Salt Lake City.
June 9, 2010
GE nets fluorescent imaging grant
By
AuntMinnie.com staff writers
GE Global Research has received a four-year, $4 million grant from the U.S. National Institutes of Health to develop a fluorescent nerve imaging agent and surgical system.
June 8, 2010
Aposense completes IPO
By
AuntMinnie.com staff writers
Molecular imaging and therapy developer Aposense has wrapped up its initial public offering (IPO) in the Israeli market.
June 8, 2010
Radiation dose must be reduced for molecular breast imaging
By
Wayne Forrest
SALT LAKE CITY - Although molecular breast imaging techniques have the potential to carve out a role in screening, dose must be lowered to achieve a comparable benefit-to-risk ratio to mammography, according to a study presented Monday at the SNM annual meeting.
June 8, 2010
Previous Page
Page 261 of 440
Next Page